The Florida federal judge overseeing the Zantac multidistrict litigation has dismissed all claims, without leave to amend, against manufacturers of ranitidine, the generic or store brand version of the prescription medication Zantac, citing federal law preemption. On...
Opioid Litigation Update
Opening statements in the sprawling opioids trial pursued by the state of New York and Nassau and Suffolk counties against seven defendant manufacturers and suppliers began on June 29 with four hours of presentations. The case is the first one involving opioids to be...
J&J Settles With New York AG and Ends Its National Opioid Sales Ahead of Trial
In a settlement reached on June 26, Johnson & Johnson agreed to pay up to $263 million to the state of New York and Nassau and Suffolk counties to resolve the plaintiffs’ claims that the pharmaceutical giant had contributed to the nationwide opioid crisis that has...
Litigation Update: Judge Grants GlaxoSmithKline Motion of Summary Judgment in Zofran MDL
In a 68-page order issued on June 1, the federal judge presiding over the Zofran MDL reversed his 2019 decision and granted GSK’s motion for summary judgment on the basis of pre-emption, essentially ending the multi-district litigation against the pharmaceutical...
Litigation Update: Defense Argues That Plaintiffs’ Expert Fails to Establish Link Between Zofran and Heart Defects
In a hearing on March 24 in the Zofran Products Liability MDL, counsel for defendant GlaxoSmithKline asked U.S. District Judge F. Dennis Saylor IV to grants its motion for summary judgment, arguing that the plaintiffs’ own expert failed to make a link between the drug...
Litigation Update: Zofran MDL Set to Start in the Fall
U.S. District Judge F. Dennis Saylor IV, who is handling the first bellwether in the MDL that relates to Zofran, has announced the date of October 18th as the potential start of the trial. Plaintiffs allege that Zofran, a drug manufactured by GlaxoSmithKline to ease...
Litigation Update: Valsartan Manufacturers to Face Fraud Claims
On January 29, the judge presiding over the Valsartan litigation, US District Judge Robert B. Kugler refused to dismiss claims of fraud brought by the consumers against the defendant manufacturers in three master complaints; similar claims against wholesalers and...
Litigation Update: Diverse Leadership Team Appointed in Elmiron Vision Loss MDL
Women make up a majority of the group of 25 attorneys appointed by a New Jersey federal judge on January 22 to the Elmiron MDL leadership team; the team also includes a significant number of minority women and younger attorneys who have never served in leadership...
Litigation Update: Clearview Al Privacy Lawsuit Remanded to State Court
Clearview Al, a facial recognition technology company, is facing a series of lawsuits. Plaintiffs claim that the company was “scraping together” facial data from various social media platforms such as Facebook, Instagram and Twitter and selling access to a compiled...
Litigation Update: Diversity Governs in Elmiron’s Plaintiff Steering Committee
Consumers in the Elmiron MDL against Johnson & Johnson (J&J) informed a New Jersey federal judge that they have chosen diverse representation to serve on the plaintiff steering committee. The committee is diverse in a number of ways, including ethnicity,...